Darren Smyth blogs for Spicy IP about Glivec decision
In a guest post for the Spicy IP blog, partner Darren Smyth expands upon the issues raised in his earlier post for The IPKat about the decision of the Indian Supreme Court in denying Novartis a patent for Glivec.
@
We use cookies to give you the best online experience. More details are available via our privacy policy. Please let us know if you agree to these cookies.
We use cookies, which are small text files, to improve your experience on our website and show you personalised content. You can allow all or manage them individually.
You can find out more via our privacy policy at any time.
Essential
These cookies are needed for essential functions. Standard cookies can’t be switched off and they don’t store any of your information.
On
Analytics
These cookies gather information such as how many people are using our site or which pages are popular to help improve user experience. Switching off these cookies means we can’t gather information to improve the experience.
Off
On
Social media & third party
These cookies allow us to unlock insights about website visitors that may come via the campaigns we run on third party websites.
